ARTICLE | Clinical News
Kyowa Hakko begins Phase II in Europe
June 6, 2001 7:00 AM UTC
Kyowa Hakko (Tokyo, Japan) will begin this month a European Phase II trial of its KW-7158 compound, which acts on peripheral sensory nerves, to treat urinary incontinence. ...